New modified release tablets of Bisoprolol fumarate (cas 104344-23-2) for the treatment of hypertension: characterization and in vitro evaluation
-
Add time:08/03/2019 Source:sciencedirect.com
ObjectivesThe purpose of the study was to develop sustained release tablets containing Bisoprolol fumarate (cas 104344-23-2) and an innovative combination of Precirol ATO5 and hydroxypropyl methylcellulose, in order to conclude upon: properties of pharmaceutical tablet formulations, drug-excipients interactions, evaluate their in vitro release behavior.
We also recommend Trading Suppliers and Manufacturers of Bisoprolol fumarate (cas 104344-23-2). Pls Click Website Link as below: cas 104344-23-2 suppliers
Prev:Homonojirimycin analogues and their glucosides from Lobelia sessilifolia and Adenophora spp. (Campanulaceae)
Next:The Maillard reaction of Bisoprolol fumarate (cas 104344-23-2) with various reducing carbohydrates) - 【Back】【Close 】【Print】【Add to favorite 】